Comments
Loading...
Leap Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:LPTX | Benzinga
Leap Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.380
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Leap Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LPTX | Leap Therapeutics | -$0.51 | -$0.38 | — | — | $0.00 | — | — | — | 05/12/2025 | Get Alert |
| LPTX | Leap Therapeutics | -$0.46 | -$0.38 | -$0.37 | 2.63% | $0.00 | — | $0.00 | — | 03/26/2025 | Get Alert |
| LPTX | Leap Therapeutics | -$0.51 | -$0.48 | -$0.44 | 8.33% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
| LPTX | Leap Therapeutics | -$0.91 | -$0.43 | -$0.52 | -20.93% | $0.00 | — | $0.00 | — | 08/12/2024 | Get Alert |
| LPTX | Leap Therapeutics | -$3.24 | -$0.58 | -$0.51 | 12.07% | $0.00 | — | $0.00 | — | 05/13/2024 | Get Alert |
| LPTX | Leap Therapeutics | -$1.10 | -$0.55 | -$0.46 | 16.36% | $0.00 | — | $0.00 | — | 03/18/2024 | Get Alert |
| LPTX | Leap Therapeutics | -$1.30 | -$0.58 | -$0.51 | 12.07% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| LPTX | Leap Therapeutics | -$1.50 | -$0.90 | -$0.91 | -1.11% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| LPTX | Leap Therapeutics | -$0.90 | -$1.00 | -$3.20 | -220.00% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| LPTX | Leap Therapeutics | -$1.00 | -$1.10 | -$1.10 | 0.00% | $375.00K | $1.20M | $0.00 | -100.00% | 03/24/2023 | Get Alert |
| LPTX | Leap Therapeutics | -$1.40 | -$1.20 | -$1.30 | -8.33% | $375.00K | — | $0.00 | — | 11/14/2022 | Get Alert |
| LPTX | Leap Therapeutics | -$1.20 | -$0.10 | -$1.50 | -1400.00% | $375.00K | $80.00K | $0.00 | -100.00% | 08/12/2022 | Get Alert |
| LPTX | Leap Therapeutics | -$1.20 | — | -$0.90 | — | $375.00K | — | $0.00 | — | 05/13/2022 | Get Alert |
| LPTX | Leap Therapeutics | -$0.90 | -$1.10 | -$1.00 | 9.09% | $375.00K | $310.00K | $375.00K | 20.97% | 03/11/2022 | Get Alert |
| LPTX | Leap Therapeutics | -$0.90 | -$1.10 | -$1.40 | -27.27% | $375.00K | $1.51M | $375.00K | -75.17% | 11/12/2021 | Get Alert |
| LPTX | Leap Therapeutics | -$1.20 | -$1.20 | -$1.20 | 0.00% | $375.00K | $280.00K | $375.00K | 33.93% | 08/13/2021 | Get Alert |
| LPTX | Leap Therapeutics | -$5.50 | -$1.20 | -$1.20 | 0.00% | $375.00K | $190.00K | $375.00K | — | 05/14/2021 | Get Alert |
| LPTX | Leap Therapeutics | -$3.20 | — | -$0.90 | — | $0.00 | — | $375.00K | — | 03/12/2021 | Get Alert |
| LPTX | Leap Therapeutics | -$3.30 | -$1.30 | -$0.90 | 30.77% | $0.00 | $1.00M | $375.00K | -62.50% | 11/12/2020 | Get Alert |
| LPTX | Leap Therapeutics | -$3.70 | -$1.80 | -$1.20 | 33.33% | $0.00 | — | $375.00K | — | 08/13/2020 | Get Alert |
| LPTX | Leap Therapeutics | -$4.70 | — | -$5.50 | — | $0.00 | — | $375.00K | — | 05/14/2020 | Get Alert |
Leap Therapeutics (LPTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-26 | $-0.37 | $-0.38 | 2.63 % |
| Q3 | 2024-11-13 | $-0.44 | $-0.48 | 8.33 % |
| Q2 | 2024-08-12 | $-0.52 | $-0.43 | -20.9 % |
| Q1 | 2024-05-13 | $-0.51 | $-0.58 | 12.1 % |
Leap Therapeutics (LPTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2023-03-24 | $0 | $1.20M | -100.0 % |
| Q2 | 2022-08-12 | $0 | $80.00K | -100.0 % |
| Q4 | 2022-03-11 | $375.00K | $310.00K | 21.0 % |
| Q3 | 2021-11-12 | $375.00K | $1.51M | -75.2 % |
FAQ
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics (LPTX) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Leap Therapeutics (NASDAQ:LPTX)?
The Actual EPS was $-0.37, which beat the estimate of $-0.38.
What were Leap Therapeutics’s (NASDAQ:LPTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
